![]() It is especially true about children with a lower ability to recount their signs and possibly varying symptoms than adults are. The differentiation of these symptoms from severe asthma exacerbation is difficult. The signs of COVID-19 in patients with asthma include cough, breath shortness, and chest tightness. The CDC currently classifies uncontrolled moderate to severe asthma as a high-risk group susceptible to severe COVID-19. Another study claimed the asthma prevalence of 1.82% among COVID patients. The studies performed in China and the United States reported ≤ 1% and 7.4–17% prevalence for asthma in patients with COVID-19, respectively. Ĭurrently, asthma risk factors in children induced by COVID-19 are not clear. Therefore, coronaviruses, which are respiratory viruses, have been shown to contribute to the infections of the respiratory tract and asthma exacerbations. ![]() Respiratory viruses are usually regarded as asthma triggers. In the United States, asthma is among the most prevalent chronic diseases affecting 8–9% of the population, and its acute exacerbations are considered as a common reason for hospitalizations and/or visits to the emergency rooms. Some comorbidities exacerbate COVID-19 outcomes: hypertension, chronic obstructive pulmonary disease, diabetes mellitus, cardiovascular disease, obesity, and asthma. Three months following the first emergence, about 2.6 million cases were reported globally due to high community transmission. Moreover, the causing agent survives in respiratory droplets and fomites. The diseases spread rapidly in the community due to the easy transmission of the virus, even from asymptomatic patients. Coronavirus disease 2019 (COVID-19) rapidly spread worldwide, characterized by severe pneumonia and other complications, such as death in highly severe cases. COVID-19 presentations are more severe in the asthma-like group.Īs a new beta coronavirus, the severe acute respiratory syndrome coronavirus two was first identified in December 2019. Family history of asthma and previous history of asthma and allergic rhinitis are risk factors for asthma-like after COVID-19 hospitalization. We found an asthma-like prevalence of 41.5% in the cohort of COVID-19 hospitalized children. Rates of signs and symptoms during hospitalization were significantly higher in patients with COVID-19 and past medical history of asthma. The asthma-like group cases had a significantly familial history of asthma (63.0%), past medical history of asthma (33.3%), and Allergic rhinitis (85.2%). 60.9% of the COVID-19 patients were male. In follow-up, most of the COVID-19 hospitalized patients (N = 42) (58.5%) were not affected by asthma-like symptoms. Asthma-like co-morbids and risk factors were evaluated and compared between the two groups. Patients with asthma-like diagnoses in follow up defined as asthma-like groups, and patients without any sign of asthma were categorized as the non-asthma group. Clinical and laboratory data were recorded, and after discharge, patients were followed and visited for cough and asthma evaluation one, 2 and 6 months later. During the COVID-19 pandemic, 69 hospitalized pediatric patients admitted with COVID-19 were observed from February 2020 to January 2021. This prospective study was carried out in a tertiary referral center. Present study aimed to determine the risk of developing Persistent cough and asthma-like symptoms in hospitalized children due to COVID-19. Coronavirus is shown to contribute to respiratory tract infections that can lead to prolonged cough and asthma. Respiratory viruses are the main triggers of asthma.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |